Transcode Therapeutics, Inc.

Nasdaq:RNAZ

Pharmaceutical Preparations·BOSTON, MA

CEO

Fitzgerald Thomas A

CFO

Fitzgerald Thomas A

Financials

19 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K/A	FY 2024	12/31/24	4/30/25	→
10-K	FY 2024	12/31/24	4/15/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

12 shown

Filed	Period
4/5/24	Q1 FY2024	→
1/16/24	Q4 FY2024	→
11/14/23	Q4 FY2023	→
3/31/23	Q1 FY2023	→
2/17/23	Q1 FY2023	→
2/1/23	Q1 FY2023	→
↓

News (8-K)

62 shown

Filed	Type	Description
3/3/26	Reg FD	Unregistered Sales of Equity Securities	→
2/23/26	Reg FD	Regulation FD Disclosure	→
2/5/26	Reg FD	Regulation FD Disclosure	→
1/6/26	Reg FD	Regulation FD Disclosure	→
12/23/25	Other	Other Events	→
12/22/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

36 shown

Filed	Form	Description
12/12/25	S-3	S-3	→
3/25/25	424B5	424B5	→
12/6/24	S-1	S-1	→
7/24/24	424B5	424B5	→
7/22/24	424B5	424B5	→
4/29/24	ARS	ARS	→
↓

Filing History(276 filings)

TypeDateAccessionPeriodSize

DEFA14A

Mar 3, 2026

0001104659-26-022837DEFA14A

—

119.5 KB

8-K

Mar 3, 2026

0001104659-26-022830FORM 8-K

Mar 2, 2026

316.3 KB

8-K

Feb 23, 2026

0001104659-26-018362FORM 8-K

Feb 23, 2026

201.2 KB

8-K

Feb 5, 2026

0001104659-26-010668FORM 8-K

Feb 5, 2026

201.5 KB

SCHEDULE 13G/A

Jan 7, 2026

0001535610-26-000003

—

9.1 KB

8-K

Jan 6, 2026

0001104659-26-001097FORM 8-K

Jan 6, 2026

205.7 KB

DEFA14A

Dec 23, 2025

0001104659-25-124230DEFA14A

—

466.2 KB

8-K/A

Dec 23, 2025

0001104659-25-124226FORM 8-K/A

Oct 8, 2025

692.9 KB

EFFECT

Dec 22, 2025

9999999995-25-003889

—

1.7 KB

Dec 22, 2025

0001104659-25-123777OWNERSHIP DOCUMENT

Oct 6, 2025

10.7 KB

Dec 22, 2025

0001104659-25-123775OWNERSHIP DOCUMENT

Dec 19, 2025

10.4 KB

8-K

Dec 22, 2025

0001104659-25-123500FORM 8-K

Dec 19, 2025

221.6 KB

S-3

Dec 12, 2025

0001104659-25-120665S-3

—

1.2 MB

8-K

Dec 11, 2025

0001104659-25-120146FORM 8-K

Dec 11, 2025

242.4 KB

10-Q

Nov 14, 2025

0001829635-25-00000410-Q

Sep 30, 2025

7.3 MB

SCHEDULE 13G/A

Nov 10, 2025

0000886982-25-001440

—

16.6 KB

SCHEDULE 13D/A

Oct 28, 2025

0001104659-25-103292

—

14.1 KB

DEFA14A

Oct 27, 2025

0001104659-25-102364DEFA14A

—

105.6 KB

8-K

Oct 27, 2025

0001104659-25-102361FORM 8-K

Oct 27, 2025

300.7 KB

DEFA14A

Oct 17, 2025

0001104659-25-100459DEFA14A

—

149.3 KB

8-K/A

Oct 17, 2025

0001104659-25-100456FORM 8-K/A

Oct 8, 2025

352.9 KB

SCHEDULE 13D

Oct 16, 2025

0001104659-25-100081

—

84.9 KB

8-K

Oct 14, 2025

0001104659-25-099029FORM 8-K

Oct 13, 2025

4.1 MB

DEFA14A

Oct 8, 2025

0001104659-25-097937DEFA14A

—

184.5 KB

8-K/A

Oct 8, 2025

0001104659-25-097919FORM 8-K/A

Oct 8, 2025

392.9 KB

25 filings shown

Transcode Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(276 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/22/25	3	OWNERSHIP DOCUMENT	→
12/22/25	3	OWNERSHIP DOCUMENT	→
11/6/24	SC 13G/A	SC 13G/A	→
7/26/24	SC 13G	SC 13G	→
6/21/24	SC 13D	SC 13D	→
6/18/24	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
1/7/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/22/25	EFFECT	EFFECT	→
11/10/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/28/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
10/16/25	SCHEDULE 13D	SCHEDULE 13D	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓